Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients

Similar documents
Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Vinblastine (Lymphoma)

Gemcitabine and Cisplatin (urology)

Nivolumab. Nivolumab

Traztuzumab (Herceptin)

Gemcitabine and carboplatin (Breast)

Brentuximab vedotin. Brentuximab vedotin

Pazopanib (Votrient ) oral for renal tumours

Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours.

High dose cytarabine (Lymphoma)

For the Patient: LUAVPG (Carboplatin Option)

Gemcitabine (Gemzar )

Intravenous anti-cancer treatment

1. and it is more than 12 hours until your next dose, take the missed dose and continue with your normal schedule

Gemcitabine and carboplatin (Lung)

Oral cyclophosphamide in ovarian cancer

Weekly standard dose. Paclitaxel (Taxol) and carboplatin

Cisplatin and radiotherapy to the

IVAC IVAC (Lymphoma) 1277 IVAC (Lymphoma) Page 1 of 6

Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

Gemcitabine and carboplatin (Lung)

Pemetrexed (Alimta )

Cisplatin and gemcitabine (GI)

Pentostatin (Nipent )

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre

Eloxatin Oxaliplatin concentrated solution for injection

Alectinib (Alecensa ) Alectinib (Alecensa )

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles.

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer)

Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC)

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes

Epirubicin. Epirubicin

The treatment is given every 3 weeks for 6 to 8 cycles.

Abemaciclib (Verzenios ) Abemaciclib (Verzenios )

Ibrutinib (Imbruvica )

Capecitabine (Xeloda) tablets

Doxorubicin & Ifosfamide

Paclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Cisplatin and Capecitabine

Mitomycin C and Fluorouracil

Everolimus. Information for patients Sheffield Kidney Institute (Renal Unit)

Vinorelbine (Oral) Oral Vinorelbine

Paclitaxel (Taxol) and carboplatin

Sorafenib (Nexavar ) For thyroid carcinoma

Obinutuzumab (lymphoma) Obinutuzumab (lymphoma)

Azithromycin and Chronic Obstructive Pulmonary Disease (COPD) Information for patients

Capecitabine (Xeloda )

Tamoxifen Tamoxifen. Your treatment Your doctor or nurse clinician has prescribed for you a treatment which includes the hormonal therapy tamoxifen.

Leflunomide Treatment Rheumatology Patient Information Leaflet

For the Patient: LUAVPEM

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Oral Etoposide (Lymphoma)

Haematology. R - CEPP Chemotherapy

Oral anti-cancer treatment

Pemetrexed (Alimta ) and cisplatin

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Myeloma Haematology and Transplant Unit MPT

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

Hospital No. Weston Park Hospital contact number

Gemcitabine and Cisplatin

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 of a 28 day cycle. You will have 2, 3 or 6 cycles.

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

Chemotherapy. In this fact sheet: Chemotherapy: English

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.

Myeloma Haematology and Transplant Unit CTD1

Paclitaxel and Carboplatin

Plasma-derived products Information for patients

Myeloma Haematology and Transplant Unit

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.

Propranolol treatment for infantile haemangioma

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

DHAP DHAP Your treatment dexamethasone Possible side effects

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

GDP GDP Gemcitabine, Dexamethasone, CisPlatin Your treatment Day 1 Days 1 to 4 Day 8 dexamethasone

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours

TCH: Docetaxel, Carboplatin and Trastuzumab

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

Methotrexate for inflammatory bowel disease: what you need to know

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: LUAVPP (Carboplatin Option)

Your treatment. 240 BEP 3 Days Page 1 of 6

Ajmaline challenge for Brugada Syndrome Information for patients

Department of Clinical Haematology. Chemotherapy. Information for patients. Page 1 of 12

For the Patient: Bendamustine Other names: TREANDA

Patient guide to Capecitabine chemotherapy with radiotherapy for rectal cancer

For the Patient: ULUAVPMTN

Oxford Centre for Respiratory Medicine Ultrasound guided pleural biopsy Information for patients

455 Pemetrexed (Alimta ) cisplatin Page 1 of 6

Iron treatment for people with chronic kidney disease (CKD)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

Transarterial Chemoembolization (TACE)

Trastuzumab (Early breast cancer)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Haematology Mycophenolate Mofetil Information for patients

For the Patient: LUAVNP

Tocilizumab Tocilizumab

For the Patient: Fludarabine injection Other names: FLUDARA

Transcription:

Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients

This booklet has been written to give you more information about bevacizumab (commonly known as Avastin). This is a drug that can be given to people with Neurofibromatosis Type 2 (NF2) to try and stop, shrink, or slow the growth of schwannomas (benign nerve tumours). What is Avastin? Avastin is a type of drug known as a monoclonal antibody. Monoclonal antibodies are able to recognise and then stick to specific proteins on the surface of tumour cells. They are sometimes called a targeted therapy because they are designed to target specific cells. Monoclonal antibodies work by triggering the body s immune system to attack the tumour cells, causing the cells to destroy themselves. They also block specific proteins from being activated, that would normally help the tumour cell to grow. This may stop the cells from growing and dividing, and may also prevent the tumour cell from developing a new blood supply. How does Avastin work? Avastin stops the tumour from developing new blood vessels. This reduces the supply of oxygen and nutrients, which can cause the tumour to shrink, stop growing or grow more slowly. This kind of drug is called an angiogenesis inhibitor. page 2

Why have I been prescribed Avastin? Avastin is given to people with NF2 when a schwannoma has grown by a specific amount or more over the previous year. The schwannoma will be measured by looking at and comparing MRI scans over the course of a year. Evidence suggests that Avastin is more effective in faster growing tumours. National guidelines state that patients need to have schwannomas that meet the specific growth rate criteria for them to be considered for treatment with Avastin. If the NF2 Centre in Oxford decides you meet the criteria for Avastin treatment, then your case will be reviewed by other NF2 Centres. This is because we are not authorised to give this treatment until it is approved by a second national centre. Avastin is given for the treatment of NF2 initially for six months, with three monthly MRI scans and clinic reviews. If a tumour starts to grow despite having Avastin treatment, then the drug will be stopped. The drug will also be stopped if you suffer significant side effects. These are discussed later in this booklet. Avastin cannot be given one month before or after any surgical procedure or operation, because it can affect how well you will heal. page 3

What does Avastin look like? Avastin comes as a colourless fluid. It is given through a drip into a vein (intravenous infusion), usually in the arm. It is normally given once every two to three weeks. The infusion is given over 90 minutes. If you tolerate the drug well this time can be reduced to 60 and then 30 minutes. You will be asked to remain at the hospital for some time after each of the first few doses of Avastin, to make sure you have no reaction from the infusion. When you have received several doses of Avastin you will be able to go home after a shorter amount of time. What will happen before I can have Avastin? Before Avastin can be given, you will need to meet certain screening criteria. This includes blood tests, a urine test, measuring your blood pressure, measuring your height and asking you some questions about your quality of life. MRI scans of your head and hearing tests will also be done, to give us a baseline so that we can measure the effect of the drug following treatment. We will ask you to sign a consent form to confirm you are happy to go ahead with the treatment. Before each treatment we will take blood and urine tests, your blood pressure and your weight. Will Avastin affect my fertility? Although we have no evidence that Avastin affects future fertility, if you are male you will be offered sperm preservation (sperm banking) and if you are female you will be offered egg/ embryo preservation if you wish to, prior to starting Avastin. page 4

On-going monitoring as part of your Avastin treatment As a condition of being on Avastin, you will need to have regular reviews to monitor your response to the treatment. This is a requirement from the Highly Specialised Services commissioning team that funds your treatment and applies to all patients receiving Avastin at the four National NF2 Centres across the UK. You will be asked to come for an MRI scan and Avastin clinic appointment before you begin your treatment. You will also need to come for an MRI scan and to the Avastin clinic at three monthly intervals in Year 1 and at six monthly intervals in Year 2. The Avastin clinic appointment will include: a neurology assessment a quality of life questionnaire an audiology assessment (hearing test), if this applies a timed 10 metre walk, if this applies. After 24 months you will have a discussion with the NF2 Team about your response to the treatment and whether this is still the most appropriate management for your tumour(s). If the team recommend that you continue to receive Avastin treatment after Year 2, you will carry on having MRI scans and coming to the Avastin clinic every 6 months, for as long as you are being treated. Should you stop receiving Avastin, you will still be required to come to regular Avastin clinic appointments and for MRI scans up to 3 years after the last dose. This is to monitor the possible long-term side effects of Avastin. page 5

What are the side effects of Avastin? As with any drugs, Avastin can cause side effects. Each person reacts very differently to drugs and some people will have very few side effects while others may experience more. The side effects described here will not affect everyone who is on Avastin. The side effects can be put into two categories: 1. Side effects that relate to the infusion (side effects that occur during or up to or 24 hours after you have received the drug). 2. Side effects that may occur for days or weeks after receiving the drug. Very few people have infusion-related reactions. If they do occur, they are often mild and rarely severe. If a reaction does happen it is most commonly during or shortly after the first or second infusion. This is why you need to remain in hospital for a longer period after receiving the first few infusions. If you have a reaction during the infusion, it can be stopped and any side effects you experience can be treated. During your treatment you will be monitored closely, but it is important to let the nurse or doctor know if you do not feel well or have any of the following symptoms: flu-like symptoms, such as fever, chills or aching all over red, warm and itchy lumps on your skin (like nettle rash) feeling that your lips are swelling or that your tongue or throat is swollen feeling breathless, wheezing, developing a cough or suddenly having difficulty breathing pain in your tummy or your back any tightness in your chest or pain across your chest. It is rare for these infusion related reactions to happen several hours after your treatment, but if you do develop any of these symptoms or feel unwell after you get home it is important to page 6

contact your local treatment centre straight away, or go to your local emergency department. Feeling sick or being sick This can happen after the treatment and may last a few days. Your doctor can give you anti-sickness medication to help with this. There are lots of anti-sickness medications available, so if your sickness is not controlled or continues, we can give you a different anti-sickness medicine that may suit you better. Tiredness and generally feeling weak NF2 may already make you feel tired, and you may find you need extra rest following your treatment. Loss of appetite You may find you do not feel like eating. The specialist nurse or dietitian can give you advice about eating well during your treatment and any dietary supplements that you may need. Diarrhoea This can be controlled with medication, but it is important to tell your doctor or nurse if the diarrhoea is severe or it continues for more than a day. It is important to drink more fluids if you have diarrhoea, so that you don t become dehydrated. High blood pressure Avastin can sometimes cause high blood pressure, which is why we monitor your blood pressure regularly. High blood pressure can usually be controlled by tablets, if needed. Sore mouth and mouth ulcers Your mouth may become sore during treatment or you may notice small ulcers. Drinking clear fluids, if you can, may help. You could also use a non-alcohol mouthwash. Slow wound healing Wounds can take longer to heal when you are taking Avastin, so it is important to let the doctor or nurse know if you have any concerns. page 7

Constipation Please let the doctor or nurse know if you become constipated, as they can give you advice about a high fibre diet and prescribe some laxatives if needed. If you have black, tarry (sticky) stools it is important to let your doctor know straight away. Bleeding Avastin can sometimes cause bleeding problems. It is important to let the doctor or nurse know if you take medication to thin your blood, such as aspirin or warfarin. If you cough up fresh blood or old blood (which will look like coffee grounds), it is important to let your doctor know straight away. Blood clots Avastin can cause an increased risk of developing blood clots. It is important to look out for and report straight away any chest pain, breathlessness, or red and painful swellings in an arm or leg. Do let the doctor or nurse know if anyone in your family has ever had a blood clot. Lower resistance to infection This is also called neutropenia and can develop if the treatment lowers the level of white cells in your blood, making you more prone to infection. It is important to contact your treating doctor or nurse straight away if your temperature goes above 38 C (100.4 F), or if you suddenly become unwell even if you do not have a temperature. Changes in the way your heart works This is very rare, but it is important to let the doctor or nurse know if you have any breathlessness, chest pain or ankle swelling. Changes in the way your kidneys work The treatment can sometimes affect the kidneys, so you will have regular urine tests during your treatment to check your kidneys are working well. page 8

Parenthood Avastin cannot be given during pregnancy. It is important not to become pregnant or father a child whilst receiving Avastin, as not enough is known about how the treatment would affect a developing baby. Breastfeeding should be discontinued during and for six months after treatment. Contraception It is important to use an effective method of contraception both during your treatment and for at least six months afterwards. You can ask your treating doctor or nurse for more information about this. Other medications It is important to let the treating doctor or nurse know the medications you are taking, including any over the counter or herbal remedies. This is to make sure that they don t have any reactions with Avastin. page 9

How to contact the NF2 team If you need further information, you can contact the Oxford NF2 Team by phone, text or email: Telephone: 01865 231 741 (Monday to Friday, 9.00am to 4.00pm) Mobile: 07747 795 588 Email: nf2@ouh.nhs.uk Alternatively you can visit our website: Website: www.ouh.nhs.uk/nf2 NF2 Specialist Nurse in Southampton: The Southampton based Specialist Nurse is part-time and can be contacted from Monday to Thursday, between 8.00am and 4.30pm. Telephone: 02381 204 973 Mobile: 07747 837 593 page 10

page 11

If you have a specific requirement, need an interpreter, a document in Easy Read, another language, large print, Braille or audio version, please call 01865 221 473 or email PALSJR@ouh.nhs.uk Author: Wendy Howard, NF2 Advanced Nurse Practitioner March 2016 Review: March 2019 Oxford University Hospitals NHS Foundation Trust Oxford OX3 9DU www.ouh.nhs.uk/information OMI 13135P